Supernus Announces FDA Acceptance of sNDA to Add Migraine to Trokendi XR Label
October 22, 2015 at 18:39 PM EDT
Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) announced today that the United States Food and Drug Administration (FDA) has accepted for ...
